NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.

Abstract

OBJECTIVES To evaluate the efficacy, safety, and tolerability of repeated NGX-4010 treatments in the open-label extension phase of a 52-week study in patients with neuropathic pain due to HIV-associated distal sensory polyneuropathy (HIV-DSP). METHODS Patients completing the 12-week, randomized, double-blind phase of the study could enter a 40-week, open… (More)
DOI: 10.1097/AJP.0b013e318287a32f

Topics

Statistics

050100150201520162017
Citations per Year

Citation Velocity: 30

Averaging 30 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Simpson2014NGX4010AC, title={NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.}, author={David M. Simpson and Stephen Brown and Jeffrey K Tobias and Geertrui F. Vanhove}, journal={The Clinical journal of pain}, year={2014}, volume={30 2}, pages={134-42} }